Clinical or subclinical hyperparathyroidism is one of the most common endocrine disorders.
Excessive secretion of parathyroid hormone is most frequently caused by an adenoma of≥ …

The parathyroid glands, which usually are situated behind the thyroid gland, secrete
parathyroid hormone, or PTH, which helps maintain calcium homeostasis. Primary …

The clinical diagnosis of primary hyperparathyroidism is based largely on serum laboratory
test results, as patients often are asymptomatic. Surgery, often with bilateral exploration of …

Objective The aim of this study was to evaluate the efficacy of dual-phase 99mTc-
methoxyisobutylnitrile (MIBI) parathyroid scintigraphy (PS) and ultrasound (US) in primary …

As more patients present with the incidental diagnosis of primary hyperparathyroidism due
to biochemical screening, treatment guidelines have been developed for the treatment of …

The major factor influencing scintigraphic detection of abnormal parathyroid glands seems
to be their size. However, false-negative results have been reported in large glands while …

There is a considerable discrepancy in the literature concerning the sensitivity of parathyroid
scintigraphy (PS) with 99m Tc-MIBI. We therefore analyzed our own data and compared …

Objective Parathyroid scintigraphy using 99m Tc-MIBI is not currently considered a valuable
diagnostic tool for the localization of involved glands in patients with secondary …

Hypersecretion of parathormone in primary hyperparathyroidism is common, occurring in
approximately 1 in 500 women and 1 in 2,000 men per year in their fifth to seventh decades …

Secondary hyperparathyroidism (sHPT) is a major complication for patients with end-stage
renal disease on long-term hemodialysis or peritoneal dialysis. When the disease is …